Jason Wuttke
Child & Adolescent Psychiatry · New Orleans, LANPI 1114942083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 589 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 15.8% — the pattern of someone who eats at a lot of different presentations. Among child & adolescent psychiatry clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 589 payments — averaging $18.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Tris Pharma Inc$1K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Ironshore Pharmaceuticals Inc.$882
- Corium, LLC$682
- Supernus Pharmaceuticals, Inc.$676
- plus $5K from 19 others
What the payments were for
- Food & beverage$10,680100%
- Education$390%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 112 | $1,690 |
| Tris Pharma Inc | 66 | $1,243 |
| Takeda Pharmaceuticals U.S.A., Inc. | 51 | $1,005 |
| Ironshore Pharmaceuticals Inc. | 44 | $882 |
| Corium, LLC | 38 | $682 |
| Supernus Pharmaceuticals, Inc. | 30 | $676 |
| Noven Therapeutics, LLC | 38 | $672 |
| Otsuka America Pharmaceutical, Inc. | 36 | $658 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 34 | $617 |
| Johnson & Johnson | 27 | $559 |
| Lundbeck LLC | 24 | $468 |
| Axsome Therapeutics, Inc. | 20 | $340 |
| Collegium Pharmaceutical, Inc. | 15 | $284 |
| Neos Therapeutics, LP | 14 | $228 |
| Adlon Therapeutics L.p. | 14 | $208 |
| Shire North American Group Inc | 7 | $137 |
| Rhodes Pharmaceuticals L.p. | 6 | $116 |
| Idorsia Pharmaceuticals US Inc | 5 | $79 |
| Brainsway USA Inc | 1 | $61 |
| Vertical Pharmaceuticals, LLC | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Alfasigma USA, Inc. | 1 | $13 |
| Aytu Biopharma, Inc. | 1 | $13 |
How this compares
$10,719 in reported general payments places this provider in the 95th percentile of 70 child & adolescent psychiatry providers in Louisiana.
See all child & adolescent psychiatry providers in Louisiana →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 13 | $29,275 |
| CaplytaLumateperone Tosylate | 18 | $26,182 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $11,714 |
| Jornay PmMethylphenidate Hcl | 12 | $5,321 |
| LamictalLamotrigine | 12 | $4,223 |
| Duloxetine Hcl | 33 | $1,940 |
| Oxcarbazepine | 19 | $1,381 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 37 | $1,236 |
| Aripiprazole | 25 | $1,055 |
| Vilazodone Hcl | 12 | $982 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 39 | $926 |
| Trazodone Hcl | 39 | $518 |
| Clonazepam | 43 | $449 |
| Lithium Carbonate ErLithium Carbonate | 20 | $324 |
| Zolpidem Tartrate ErZolpidem Tartrate | 20 | $286 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $559 | $29,27513 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $617 | $26,18218 claims |
| Axsome Therapeutics, Inc.Auvelity | $340 | $11,71411 claims |
| Ironshore Pharmaceuticals Inc.Jornay Pm | $882 | $5,32112 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 70 child & adolescent psychiatry providers in Louisiana.
Other child & adolescent psychiatry in New Orleans
- Adewale OyemadeNew Orleans$4K
- Caroline CampionNew Orleans$3K
- Myra FernandoNew Orleans$2K
- Stephen CochranNew Orleans$2K
- Lauren Kaczka-WeissNew Orleans$2K
- Jennifer GrecoNew Orleans$2K
- Cody RoiNew Orleans$1K
- Amy HudsonNew Orleans$1K
- Morgan FeibelmanNew Orleans$981
- Stephanie Gravois-RupeNew Orleans$957
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.